Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

COCP holding history

Cocrystal Pharma, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

COCP overviewAll 13F holders of COCPFull Q2 2026 holdings

Shares (Q2 2026)
4,133
Value
$4.34K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of COCP by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,133$4.34K<0.1%−511−11.0%ReducedHolders
Q1 20264,644$4.69K<0.1%+2,867+161.3%AddedHolders
Q4 20251,777$1.74K<0.1%+1,206+211.2%AddedHolders
Q3 2025571$714<0.1%−21,344−97.4%ReducedHolders
Q2 202521,915$32.7K<0.1%+5,109+30.4%AddedHolders
Q1 202516,806$23.9K<0.1%+10,676+174.2%AddedHolders
Q4 20246,130$12.4K<0.1%+5,220+573.6%AddedHolders
Q3 2024910$1.60K<0.1%+910NewHolders
Q2 20240$00.0%−20,258−100.0%Sold outHolders
Q1 202420,258$28.4K<0.1%+20,091+12,030.5%AddedHolders
Q4 2023167$288<0.1%+167NewHolders
Q3 20230$00.0%−276−100.0%Sold outHolders
Q2 2023276$660<0.1%−1,716−86.1%ReducedHolders
Q1 20231,992$3.96K<0.1%−3,023−60.3%ReducedHolders
Q4 20225,015$9.78K<0.1%+4,550+977.7%AddedConverted for a 1-for-12 splitHolders
Q3 20225,584$2.00K<0.1%+4,176+296.6%AddedHolders
Q2 20221,408$1.00K<0.1%−16,769−92.3%ReducedHolders
Q1 202218,177$10.0K<0.1%−17,094−48.5%ReducedHolders
Q4 202135,271$23.0K<0.1%+23,273+194.0%AddedHolders
Q3 202111,998$13.0K<0.1%+1,783+17.5%AddedHolders
Q2 202110,215$13.0K<0.1%+4,126+67.8%AddedHolders
Q1 20216,089$8.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.